Paloma Partners’s Pfizer PFE Stock Holding History

Paloma Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-27,741	Closed	-$803K	–	875
2024 Q3	$803K	Sell	27,741 -103,332	-79%	-$3.01M	0.02%	483
2024 Q2	$3.67M	Buy	+131,073	New	+$3.61M	0.1%	204
2022 Q4	–	Sell	-3,974	Closed	-$191K	–	1109
2022 Q3	$174K	Buy	+3,974	New	+$193K	0.01%	749
2022 Q2	–	Sell	-25,482	Closed	-$1.32M	–	1599
2022 Q1	$1.32M	Buy	25,482 +2,382	+10%	+$124K	0.04%	346
2021 Q4	$1.36M	Buy	+23,100	New	+$1.14M	0.02%	574
2021 Q3	–	Sell	-160,552	Closed	-$6.29M	–	1693
2021 Q2	$6.29M	Buy	+160,552	New	+$6.24M	0.11%	157
2021 Q1	–	Sell	-39,500	Closed	-$1.4M	–	2285
2020 Q4	$1.45M	Buy	39,500 +22,444	+132%	+$823K	0.04%	460
2020 Q3	$594K	Sell	17,056 -729,458	-98%	-$25.6M	0.02%	1044
2020 Q2	$23.2M	Buy	746,514 +648,910	+665%	+$22M	0.4%	29
2020 Q1	$3.02M	Sell	97,604 -17,516	-15%	-$597K	0.17%	83
2019 Q4	$4.28M	Sell	115,120 -43,271	-27%	-$1.54M	0.06%	294
2019 Q3	$5.4M	Sell	158,391 -485,153	-75%	-$17.6M	0.11%	144
2019 Q2	$26.4M	Sell	643,544 -693,574	-52%	-$27.5M	0.45%	32
2019 Q1	$53.9M	Buy	1,337,118 +995,569	+291%	+$39.9M	1.31%	6
2018 Q4	$14.1M	Buy	+341,549	New	+$14.2M	0.43%	40
2018 Q3	–	Sell	-579,988	Closed	-$22.3M	–	1847
2018 Q2	$20M	Buy	579,988 +567,530	+4,556%	+$19.4M	0.36%	31
2018 Q1	$419K	Sell	12,458 -17,215	-58%	-$592K	0.01%	1467
2017 Q4	$1.02M	Buy	+29,673	New	+$1.01M	0.01%	1027
2017 Q3	–	Sell	-341,372	Closed	-$11M	–	2350
2017 Q2	$10.9M	Buy	341,372 +186,062	+120%	+$5.87M	0.13%	116
2017 Q1	$5.04M	Buy	155,310 +53,887	+53%	+$1.7M	0.06%	302
2016 Q4	$3.13M	Sell	101,423 -256,685	-72%	-$7.84M	0.03%	443
2016 Q3	$11.5M	Buy	358,108 +174,612	+95%	+$5.84M	0.14%	91
2016 Q2	$6.13M	Buy	183,496 +11,038	+6%	+$352K	0.07%	201
2016 Q1	$4.85M	Buy	172,458 +120,896	+234%	+$3.45M	0.08%	181
2015 Q4	$1.58M	Buy	51,562 +25,336	+97%	+$797K	0.04%	454
2015 Q3	$781K	Sell	26,226 -1,299,747	-98%	-$41.7M	0.02%	787
2015 Q2	$42.2M	Buy	1,325,973 +674,000	+103%	+$22M	0.81%	14
2015 Q1	$21.5M	Buy	651,973 +597,865	+1,105%	+$19M	0.61%	20
2014 Q4	$1.6M	Buy	54,108 +9,208	+21%	+$264K	0.07%	301
2014 Q3	$1.26M	Sell	44,900 -484,213	-92%	-$13.6M	0.06%	301
2014 Q2	$14.9M	Buy	529,113 +350,119	+196%	+$9.98M	0.61%	23
2014 Q1	$5.46M	Sell	178,994 -336,665	-65%	-$10M	0.35%	63
2013 Q4	$15M	Buy	515,659 +281,570	+120%	+$8.19M	0.75%	13
2013 Q3	$6.38M	Sell	234,089 -224,185	-49%	-$6.1M	0.25%	70
2013 Q2	$12.2M	Buy	+458,274	New	+$12.7M	0.68%	24

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Paloma Partners's PFE Position: Q4 2024 in Review

Paloma Partners sold out of Pfizer (PFE) in Q4 2024, closing a stake of 27,741 shares — an estimated $803K sold.

Paloma Partners first reported a position in PFE in Q2 2013 and held it in 35 quarters. The position peaked at $53.9M in Q1 2019. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

Paloma Partners reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
Paloma Partners sold 27,741 Pfizer shares in Q4 2024, an estimated $803K.
Paloma Partners first reported a position in Pfizer in Q2 2013 and held it in 35 quarters.
Paloma Partners's Pfizer position peaked at $53.9M in Q1 2019.
2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.